13 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

BOSS-2000-2 VACUUM ERECTION DEVICE

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

COLOR SPEX

FDA UDI
FGX INTERNATIONAL INC.·00193033441855·

COLOR SPEX

FDA UDI
FGX INTERNATIONAL INC.·00193033441848·

COLOR SPEX

FDA UDI
FGX INTERNATIONAL INC.·00193033441831·

COLOR SPEX

FDA UDI
FGX INTERNATIONAL INC.·00193033441862·

MONOGRAMS SYNTHETIC MONOFILAMENT ABSORBABLE SUTURE

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

VYPRO MESH, VICRYL PROLENE PARTIALLY ABSORBABLE SYNTHETIC SURGICAL MESH

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

COLUMBUS UCR TIBIAL PLATEAU CEMENTED T2+

FDA Adverse Event
Malfunction ·AESCULAP AG & CO. KG·Product code JHW·July 24, 2015

CONCERTO II CRT-D

FDA Adverse Event
Death ·MEDTRONIC MED REL MEDTRONIC PUERTO RICO·Product code NIK·March 20, 2013

UNKNOWN DEPUY LCS STD + PATELLA

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC.·Product code HTG·February 24, 2011

NEXGEN COMPLETE KNEE SOLUTION LEGACY KNEE-POSTERIOR STABILIZED LPS-FLEX ARTICULA

FDA Adverse Event
Injury ·ZIMMER, INC.·Product code JWH·March 12, 2008

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

StimQ Peripheral Nerve Stimulator System (PNS) Model STQ4-SPR-BO US - Product Usage: is used for peripheral neural stimulation to provide therapeutic relief for chronic, intractable pain of peripheral nerve origin. The therapy utilizes pulsed electrical current to create an electrical energy field that acts on peripheral nerves in the limbs and torso to alter the transmission of pain signals to the brain.

FDA Enforcement
Class II ·Ongoing·Stimwave Technologies Inc·September 9, 2020